Manufacturing News and Research

RSS
MiMedx first quarter revenue increases to $1,044,000

MiMedx first quarter revenue increases to $1,044,000

Teleflex first quarter net revenue increases 6% to $388.7 million

Teleflex first quarter net revenue increases 6% to $388.7 million

Some bacteria avoid antibiotic treatments by going 'off the grid' like rogue secret agents

Some bacteria avoid antibiotic treatments by going 'off the grid' like rogue secret agents

Caliber opens world's largest plant-made pharmaceutical facility in Bryan

Caliber opens world's largest plant-made pharmaceutical facility in Bryan

KemPharm to formulate and develop KP106 as oral film dosage for ADHD treatment

KemPharm to formulate and develop KP106 as oral film dosage for ADHD treatment

Alkem, Karo Bio partner to license eprotirome

Alkem, Karo Bio partner to license eprotirome

NetGuarantee's inaugural transaction to help save lives from malaria

NetGuarantee's inaugural transaction to help save lives from malaria

Taro's Brampton facility regains FDA acceptable regulatory status

Taro's Brampton facility regains FDA acceptable regulatory status

A.P. Pharma targets resubmission of APF530 NDA in 2012

A.P. Pharma targets resubmission of APF530 NDA in 2012

Pharmatek purchases spray dryer for drug formulation and manufacturing

Pharmatek purchases spray dryer for drug formulation and manufacturing

Congressman Holt congratulates Vaxinnate for BARDA award to develop next generation of flu vaccines

Congressman Holt congratulates Vaxinnate for BARDA award to develop next generation of flu vaccines

Baxa increases recycling initiatives by 22%

Baxa increases recycling initiatives by 22%

Luitpold temporarily suspends distribution of drug products manufactured at Shirley, New York facility

Luitpold temporarily suspends distribution of drug products manufactured at Shirley, New York facility

Merck and Sanofi Pasteur commence Phase III trial of pediatric hexavalent combination vaccine

Merck and Sanofi Pasteur commence Phase III trial of pediatric hexavalent combination vaccine

Repligen anticipates 30% increase in total revenues for 2011

Repligen anticipates 30% increase in total revenues for 2011

Jennerex and Green Cross report positive phase 2 JX-594 clinical trial for liver cancer

Jennerex and Green Cross report positive phase 2 JX-594 clinical trial for liver cancer

Biogen Idec first quarter revenues increase 9% to $1.2 billion

Biogen Idec first quarter revenues increase 9% to $1.2 billion

Shanghai Pharmaceutical and Pfizer enter MOU to pursue potential business opportunities

Shanghai Pharmaceutical and Pfizer enter MOU to pursue potential business opportunities

Stepped up measures to tack rising painkiller abuse

Stepped up measures to tack rising painkiller abuse

ARIAD executes three exclusive out-license agreements for ARGENT cell-signaling regulation technology

ARIAD executes three exclusive out-license agreements for ARGENT cell-signaling regulation technology

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.